Cargando…
Synergistic cell inactivation by cis-dichlorodiammineplatinum in combination with 1-propargyl-5-chloropyrimidin-2-one.
A synergistic effect with respect to inactivation of human NHIK 3025 cells cultured in vitro was displayed when treatment with cis-dichlorodiammineplatinum(II) (cis-DDP) and the mitotic inhibitor 1-propargyl-5-chloropyrimidin-2-one (NY 3170) were given in simultaneous combination. Cell inactivation...
Autores principales: | Dornish, J. M., Pettersen, E. O., Oftebro, R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002188/ https://www.ncbi.nlm.nih.gov/pubmed/3663475 |
Ejemplares similares
-
The binding of cis-dichlorodiammineplatinum(II) to extracellular and intracellular compounds in relation to drug uptake and cytotoxicity in vitro.
por: Melvik, J. E., et al.
Publicado: (1992) -
Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide.
por: Yuhas, J. M., et al.
Publicado: (1980) -
N‐Acetylcysteine Modifies cis‐Dichlorodiammineplatinum‐induced Effects in Bladder Cancer Cells
por: Miyajima, Akira, et al.
Publicado: (1999) -
Combinations of single doses and fractionated treatments of cis-dichlorodiammineplatinum (II) and irradiation: effect on mouse lip mucosa.
por: Landuyt, W., et al.
Publicado: (1986) -
Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells.
por: Miyajima, A., et al.
Publicado: (1997)